Filter posts

Shooting for the Moon: Creating the Next Generation of Cancer Killers

The last morning of the 2017 BIO International Convention kicked off with a 9:00am oncology …

Expanded Access: New Opportunities for Patients and Sponsors

Patients with serious or life-threatening conditions may find themselves with no treatment options once approved …

City of South San Francisco Recognizes Contributions to Biotech Industry Growth

BIO’s Pete Pellerito yesterday received the City of South San Francisco’s first ever special recognition …

State Leaders Discuss Bioscience Economic Development

This week BIO released Bioscience Innovation in the States: Legislation and Job Creation through Public-Private …

Making Sense and Cents Out of Pharma Strategic Venture Investing

For most large pharmaceutical companies, strategic venture arms are no longer a “nice to have,” …

Unleashing CAR-T Therapies on Solid Tumors: Are We There Yet?

Chimeric antigen receptor (CAR) T cell therapies have shown dramatic results against certain blood cancers …

Tchotchke’s Abound at BIO2017

BIO2107 is filled with partnering meetings, great sessions, motivating fireside chats and a trade show …

“CEPI: A New Approach to Vaccine Funding and Innovation for Emerging Infectious Diseases”

Tuesday morning of the 2017 BIO International Convention commenced the Infectious Diseases & Vaccines Track …

Panel Takes Look at Trump’s Trade Policy

Day three of the BIO International Convention brought some heavy hitters to the stage. From …

#BIO2017 Fireside Chat: Unlocking the Power of the Genome

To Francis deSouza, genomics is a transformational force. deSouza, President and CEO of Illumina, joined …